Sequencing Osimertinib in Patients With EGFR-Mutated NSCLCByAparna Hegde, MDApril 15th 2022Aparna Hegde, MD, discusses the decision to use osimertinib as soon as possible in patients with EGFR-positive non–small cell lung cancer.